Zurich Cantonal Bank
RUBY

Zurich Cantonal Bank’s Rubius Therapeutics, Inc RUBY Stock Holding History

Zurich Cantonal Bank’s Portfolio RUBY Stock Details RUBY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,374
Closed -$19K – 2953
2022
Q1 		$19K Sell
3,374
-6,561
-66% -$41.7K ﹤0.01% 2672
2021
Q4 		$96K Sell
9,935
-658
-6% -$9.13K ﹤0.01% 2532
2021
Q3 		$189K Buy
10,593
+56
+0.5% +$1.22K ﹤0.01% 1961
2021
Q2 		$257K Buy
10,537
+3,555
+51% +$88.9K ﹤0.01% 1645
2021
Q1 		$185K Buy
+6,982
New +$102K ﹤0.01% 1829

Other funds holding RUBY

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AFM
Abbot Financial Management Andover, Massachusetts $239M AUM 27.19% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Zurich Cantonal Bank's RUBY Position: Q2 2022 in Review

Zurich Cantonal Bank sold out of Rubius Therapeutics, Inc (RUBY) in Q2 2022, closing a stake of 3,374 shares — an estimated $19K sold.

Zurich Cantonal Bank first reported a position in RUBY in Q1 2021 and held it in 5 quarters. The position peaked at $257K in Q2 2021. 72 funds tracked by Wall St. Rank hold RUBY as of Q2 2022.

  • Zurich Cantonal Bank reported no remaining Rubius Therapeutics, Inc position as of Q2 2022 after selling out during the quarter.
  • Zurich Cantonal Bank sold 3,374 Rubius Therapeutics, Inc shares in Q2 2022, an estimated $19K.
  • Zurich Cantonal Bank first reported a position in Rubius Therapeutics, Inc in Q1 2021 and held it in 5 quarters.
  • Zurich Cantonal Bank's Rubius Therapeutics, Inc position peaked at $257K in Q2 2021.
  • 72 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q2 2022.

Based on Zurich Cantonal Bank's 13F filing for Q2 2022, filed 9 Aug 2022.